{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:51:05Z","timestamp":1791481865034,"version":"4.3.4"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Craniospinal irradiation (CSI) is an indispensable part of oncological treatment for pediatric medulloblastoma. However, despite significantly improving oncological outcome, it is also associated with severe short- and long-term side effects such as inflammation and impaired neurocognition. The presence of senescent cells has been identified as a potential contributing factor to these issues. In our study, we demonstrate that p53 wild-type and c-Myc-low-expressing ONS76 medulloblastoma cells underwent senescence, a terminal and stable cell cycle arrest, after exposure to gamma irradiation (\u03b3IR). In contrast, p53-mutated UW228-3 cells exhibited apoptosis following the same treatment. ONS76 cells displayed typical senescence properties, including cell and nuclei enlargement, an active DNA damage response with stabilization of p53 and increased expression of its target gene, the CDK inhibitor p21\n                    <jats:sup>WAF1\/CIP1<\/jats:sup>\n                    , as well as elevated senescence-associated beta-galactosidase activity and lipofuscin accumulation. Knockdown of p53 or p21 expression with siRNAs abolished \u03b3IR-mediated senescence. Furthermore, overexpression of c-Myc resulted in a partial shift from senescence to cell death induction after \u03b3IR treatment, which was inhibited by using the caspase-inhibitor q-VD-OPh. The \u03b3IR-exposed ONS76 cells showed susceptibility to senolytic substances, such as the BCL-2 family inhibitor Navitoclax and the PI3K-inhibitors PX-866 and BAY80-6946, which specifically target senescent cells. In conclusion, employing senolytics on irradiated medulloblastoma cells with wild-type p53 and low c-Myc expression may lead to reduced therapeutic side effects as well as attenuate tumor relapse and potentially minimize CSI doses required for effective tumor cell elimination.\n                  <\/jats:p>","DOI":"10.1038\/s41420-026-03404-4","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:27:01Z","timestamp":1791433621000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["p53 wild-type\/low c-Myc-expressing ONS76 pediatric medulloblastoma cells become senescent after gamma-irradiation and can be eliminated by senolytic substances"],"prefix":"10.1038","volume":"12","author":[{"given":"Jessica","family":"Sonntag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronja-Linda","family":"Preugschas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Jazmati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Neuwahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Matuschek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9404-9993","authenticated-orcid":false,"given":"Marc","family":"Remke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried","family":"Budach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"H\u00f6rner-Rieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1392-9609","authenticated-orcid":false,"given":"Dennis","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"3404_CR1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3171\/2019.5.PEDS18381","volume":"24","author":"K Juraschka","year":"2019","unstructured":"Juraschka K, Taylor MD. Medulloblastoma in the age of molecular subgroups: a review. J Neurosurg Pediatr. 2019;24:353\u201363.","journal-title":"J Neurosurg Pediatr"},{"key":"3404_CR2","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23:1231\u201351.","journal-title":"Neuro Oncol"},{"key":"3404_CR3","unstructured":"Board WCoTE. Central nervous system tumours. 5th ed., vol. 6. IARC Publications; 2021."},{"key":"3404_CR4","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.ccell.2017.05.005","volume":"31","author":"FMG Cavalli","year":"2017","unstructured":"Cavalli FMG, Remke M, Rampasek L, Peacock J, Shih DJH, Luu B, et al. Intertumoral heterogeneity within medulloblastoma subgroups. Cancer Cell. 2017;31:737\u201354.e736.","journal-title":"Cancer Cell"},{"key":"3404_CR5","doi-asserted-by":"crossref","unstructured":"Seidel C, Heider S, Hau P, Glasow A, Dietzsch S, Kortmann RD. Radiotherapy in medulloblastoma-evolution of treatment, current concepts and future perspectives. Cancers (Basel). 2021;13:5945.","DOI":"10.3390\/cancers13235945"},{"key":"3404_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.neuchi.2018.01.006","volume":"67","author":"V Bernier","year":"2021","unstructured":"Bernier V, Klein O. Late effects of craniospinal irradiation for medulloblastomas in paediatric patients. Neurochirurgie. 2021;67:83\u201386.","journal-title":"Neurochirurgie"},{"key":"3404_CR7","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1093\/neuonc\/nor015","volume":"13","author":"K Edelstein","year":"2011","unstructured":"Edelstein K, Spiegler BJ, Fung S, Panzarella T, Mabbott DJ, Jewitt N, et al. Early aging in adult survivors of childhood medulloblastoma: long-term neurocognitive, functional, and physical outcomes. Neuro Oncol. 2011;13:536\u201345.","journal-title":"Neuro Oncol"},{"key":"3404_CR8","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1200\/JCO.2017.76.4696","volume":"36","author":"KR Krull","year":"2018","unstructured":"Krull KR, Hardy KK, Kahalley LS, Schuitema I, Kesler SR. Neurocognitive outcomes and interventions in long-term survivors of childhood cancer. J Clin Oncol. 2018;36:2181\u20139.","journal-title":"J Clin Oncol"},{"key":"3404_CR9","doi-asserted-by":"publisher","first-page":"5031","DOI":"10.1158\/1078-0432.CCR-23-0348","volume":"29","author":"KJ Cohen","year":"2023","unstructured":"Cohen KJ, Munjapara V, Aguilera D, Castellino RC, Stapleton SL, Landi D, et al. A pilot study omitting radiation in the treatment of children with newly diagnosed Wnt-activated medulloblastoma. Clin Cancer Res. 2023;29:5031\u20137.","journal-title":"Clin Cancer Res"},{"key":"3404_CR10","doi-asserted-by":"publisher","first-page":"4996","DOI":"10.1158\/1078-0432.CCR-23-2331","volume":"29","author":"NG Gottardo","year":"2023","unstructured":"Gottardo NG, Gajjar A. Verschlimmbesserung: craniospinal radiotherapy is essential in WNT medulloblastoma patients. Clin Cancer Res. 2023;29:4996\u20138.","journal-title":"Clin Cancer Res"},{"key":"3404_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03209-y","volume":"11","author":"S Adjemian","year":"2020","unstructured":"Adjemian S, Oltean T, Martens S, Wiernicki B, Goossens V, Vanden Berghe T, et al. Ionizing radiation results in a mixture of cellular outcomes including mitotic catastrophe, senescence, methuosis, and iron-dependent cell death. Cell Death Dis. 2020;11:1003.","journal-title":"Cell Death Dis"},{"key":"3404_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/358015a0","volume":"358","author":"DP Lane","year":"1992","unstructured":"Lane DP. Cancer. p53, guardian of the genome. Nature. 1992;358:15\u201316.","journal-title":"Nature"},{"key":"3404_CR13","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.ccell.2024.04.009","volume":"42","author":"Y Liu","year":"2024","unstructured":"Liu Y, Su Z, Tavana O, Gu W. Understanding the complexity of p53 in a new era of tumor suppression. Cancer Cell. 2024;42:946\u201367.","journal-title":"Cancer Cell"},{"key":"3404_CR14","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nrc2657","volume":"9","author":"T Abbas","year":"2009","unstructured":"Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer. 2009;9:400\u201314.","journal-title":"Nat Rev Cancer"},{"key":"3404_CR15","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ 2018. 2018;25:486\u2013541.","journal-title":"Cell Death Differ 2018"},{"key":"3404_CR16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nrm3115","volume":"12","author":"I Vitale","year":"2011","unstructured":"Vitale I, Galluzzi L, Castedo M, Kroemer G. Mitotic catastrophe: a mechanism for avoiding genomic instability. Nat Rev Mol Cell Biol. 2011;12:385\u201392.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3404_CR17","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.tcb.2017.07.004","volume":"27","author":"Y Ito","year":"2017","unstructured":"Ito Y, Hoare M, Narita M. Spatial and temporal control of senescence. Trends Cell Biol. 2017;27:820\u201332.","journal-title":"Trends Cell Biol"},{"key":"3404_CR18","doi-asserted-by":"publisher","first-page":"6031","DOI":"10.1158\/0008-5472.CAN-07-6851","volume":"68","author":"A Matheu","year":"2008","unstructured":"Matheu A, Maraver A, Serrano M. The Arf\/p53 pathway in cancer and aging. Cancer Res. 2008;68:6031\u20134.","journal-title":"Cancer Res"},{"key":"3404_CR19","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1016\/j.cell.2024.05.059","volume":"187","author":"M Ogrodnik","year":"2024","unstructured":"Ogrodnik M, Carlos Acosta J, Adams PD, d\u2019Adda di Fagagna F, Baker DJ, Bishop CL, et al. Guidelines for minimal information on cellular senescence experimentation in vivo. Cell. 2024;187:4150\u201375.","journal-title":"Cell"},{"key":"3404_CR20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.32607\/20758251-2018-10-1-4-14","volume":"10","author":"AV Borodkina","year":"2018","unstructured":"Borodkina AV, Deryabin PI, Giukova AA, Nikolsky NN. \u201cSocial Life\u201d of senescent cells: what is SASP and why study it? Acta Naturae. 2018;10:4\u201314.","journal-title":"Acta Naturae"},{"key":"3404_CR21","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.devcel.2014.11.012","volume":"31","author":"M Demaria","year":"2014","unstructured":"Demaria M, Ohtani N, Youssef SA, Rodier F, Toussaint W, Mitchell JR, et al. An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Dev Cell. 2014;31:722\u201333.","journal-title":"Dev Cell"},{"key":"3404_CR22","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1126\/science.adj7050","volume":"384","author":"JP de Magalhaes","year":"2024","unstructured":"de Magalhaes JP. Cellular senescence in normal physiology. Science. 2024;384:1300\u20131.","journal-title":"Science"},{"key":"3404_CR23","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41571-022-00668-4","volume":"19","author":"CA Schmitt","year":"2022","unstructured":"Schmitt CA, Wang B, Demaria M. Senescence and cancer\u2014role and therapeutic opportunities. Nat Rev Clin Oncol. 2022;19:619\u201336.","journal-title":"Nat Rev Clin Oncol"},{"key":"3404_CR24","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature10600","volume":"479","author":"DJ Baker","year":"2011","unstructured":"Baker DJ, Wijshake T, Tchkonia T, LeBrasseur NK, Childs BG, van de Sluis B, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011;479:232\u20136.","journal-title":"Nature"},{"key":"3404_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.pharmthera.2018.08.006","volume":"193","author":"V Myrianthopoulos","year":"2019","unstructured":"Myrianthopoulos V, Evangelou K, Vasileiou PVS, Cooks T, Vassilakopoulos TP, Pangalis GA, et al. Senescence and senotherapeutics: a new field in cancer therapy. Pharmacol Ther. 2019;193:31\u201349.","journal-title":"Pharmacol Ther"},{"key":"3404_CR26","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41568-022-00450-9","volume":"22","author":"L Wang","year":"2022","unstructured":"Wang L, Lankhorst L, Bernards R. Exploiting senescence for the treatment of cancer. Nat Rev Cancer. 2022;22:340\u201355.","journal-title":"Nat Rev Cancer"},{"key":"3404_CR27","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1080\/15384101.2016.1189044","volume":"15","author":"L Tamayo-Orrego","year":"2016","unstructured":"Tamayo-Orrego L, Swikert SM, Charron F. Evasion of cell senescence in SHH medulloblastoma. Cell Cycle. 2016;15:2102\u20137.","journal-title":"Cell Cycle"},{"key":"3404_CR28","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1016\/j.celrep.2016.02.061","volume":"14","author":"L Tamayo-Orrego","year":"2016","unstructured":"Tamayo-Orrego L, Wu CL, Bouchard N, Khedher A, Swikert SM, Remke M, et al. Evasion of cell senescence leads to medulloblastoma progression. Cell Rep. 2016;14:2925\u201337.","journal-title":"Cell Rep"},{"key":"3404_CR29","first-page":"415","volume":"7","author":"TM Remes","year":"2020","unstructured":"Remes TM, Suo-Palosaari MH, Koskenkorva PKT, Sutela AK, Toiviainen-Salo SM, Arikoski PM, et al. Radiation-induced accelerated aging of the brain vasculature in young adult survivors of childhood brain tumors. Neurooncol Pract. 2020;7:415\u201327.","journal-title":"Neurooncol Pract"},{"key":"3404_CR30","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.15252\/embr.201439245","volume":"15","author":"BG Childs","year":"2014","unstructured":"Childs BG, Baker DJ, Kirkland JL, Campisi J, van Deursen JM. Senescence and apoptosis: dueling or complementary cell fates? EMBO Rep. 2014;15:1139\u201353.","journal-title":"EMBO Rep"},{"key":"3404_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jbiotec.2016.07.028","volume":"236","author":"DP Ivanov","year":"2016","unstructured":"Ivanov DP, Coyle B, Walker DA, Grabowska AM. In vitro models of medulloblastoma: choosing the right tool for the job. J Biotechnol. 2016;236:10\u201325.","journal-title":"J Biotechnol"},{"key":"3404_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-024-02566-8","volume":"20","author":"D Jazmati","year":"2025","unstructured":"Jazmati D, Sohn D, Horner-Rieber J, Qin N, Bolke E, Haussmann J, et al. Alpha\/beta values in pediatric medulloblastoma: implications for tailored approaches in radiation oncology. Radiat Oncol. 2025;20:17.","journal-title":"Radiat Oncol"},{"key":"3404_CR33","doi-asserted-by":"publisher","DOI":"10.1111\/acel.14154","volume":"23","author":"TC Bitencourt","year":"2024","unstructured":"Bitencourt TC, Vargas JE, Silva AO, Fraga LR, Filippi-Chiela E. Subcellular structure, heterogeneity, and plasticity of senescent cells. Aging Cell. 2024;23:e14154.","journal-title":"Aging Cell"},{"key":"3404_CR34","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.1016\/j.molcel.2023.09.006","volume":"83","author":"S Magkouta","year":"2023","unstructured":"Magkouta S, Veroutis D, Pousias A, Papaspyropoulos A, Pippa N, Lougiakis N, et al. A fluorophore-conjugated reagent enabling rapid detection, isolation and live tracking of senescent cells. Mol Cell. 2023;83:3558\u201373.e3557.","journal-title":"Mol Cell"},{"key":"3404_CR35","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/sj.cdd.4401962","volume":"13","author":"MT Hemann","year":"2006","unstructured":"Hemann MT, Lowe SW. The p53-Bcl-2 connection. Cell Death Differ. 2006;13:1256\u20139.","journal-title":"Cell Death Differ"},{"key":"3404_CR36","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.4161\/cc.9.17.12799","volume":"9","author":"D Neise","year":"2010","unstructured":"Neise D, Sohn D, Budach W, Janicke RU. Evidence for a differential modulation of p53-phosphorylating kinases by the cyclin-dependent kinase inhibitor p21WAF1\/CIP1. Cell Cycle. 2010;9:3575\u201383.","journal-title":"Cell Cycle"},{"key":"3404_CR37","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1038\/sj.onc.1204487","volume":"20","author":"P Giannakakou","year":"2001","unstructured":"Giannakakou P, Robey R, Fojo T, Blagosklonny MV. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1\/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity. Oncogene. 2001;20:3806\u201313.","journal-title":"Oncogene"},{"key":"3404_CR38","doi-asserted-by":"publisher","first-page":"37949","DOI":"10.1074\/jbc.M204497200","volume":"277","author":"D Javelaud","year":"2002","unstructured":"Javelaud D, Besancon F. Inactivation of p21WAF1 sensitizes cells to apoptosis via an increase of both p14ARF and p53 levels and an alteration of the Bax\/Bcl-2 ratio. J Biol Chem. 2002;277:37949\u201354.","journal-title":"J Biol Chem"},{"key":"3404_CR39","doi-asserted-by":"crossref","unstructured":"Roussel MF, Robinson GW. Role of MYC in medulloblastoma. Cold Spring Harb Perspect Med. 2013;3:a014308.","DOI":"10.1101\/cshperspect.a014308"},{"key":"3404_CR40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","volume":"19","author":"R Dhanasekaran","year":"2022","unstructured":"Dhanasekaran R, Deutzmann A, Mahauad-Fernandez WD, Hansen AS, Gouw AM, Felsher DW. The MYC oncogene\u2014the grand orchestrator of cancer growth and immune evasion. Nat Rev Clin Oncol. 2022;19:23\u201336.","journal-title":"Nat Rev Clin Oncol"},{"key":"3404_CR41","doi-asserted-by":"crossref","unstructured":"Garcia-Gutierrez L, Delgado MD, Leon J. MYC oncogene contributions to release of cell cycle brakes. Genes (Basel). 2019;10:244.","DOI":"10.3390\/genes10030244"},{"key":"3404_CR42","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nature01119","volume":"419","author":"J Seoane","year":"2002","unstructured":"Seoane J, Le HV, Massague J. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature. 2002;419:729\u201334.","journal-title":"Nature"},{"key":"3404_CR43","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1093\/neuonc\/noac068","volume":"24","author":"N Qin","year":"2022","unstructured":"Qin N, Paisana E, Langini M, Picard D, Malzkorn B, Custodia C, et al. Intratumoral heterogeneity of MYC drives medulloblastoma metastasis and angiogenesis. Neuro Oncol. 2022;24:1509\u201323.","journal-title":"Neuro Oncol"},{"key":"3404_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06755-x","volume":"15","author":"J Neuwahl","year":"2024","unstructured":"Neuwahl J, Neumann CA, Fitz AC, Biermann AD, Magel M, Friedrich A, et al. Combined inhibition of class 1-PI3K-alpha and delta isoforms causes senolysis by inducing p21(WAF1\/CIP1) proteasomal degradation in senescent cells. Cell Death Dis. 2024;15:373.","journal-title":"Cell Death Dis"},{"key":"3404_CR45","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/acel.12445","volume":"15","author":"Y Zhu","year":"2016","unstructured":"Zhu Y, Tchkonia T, Fuhrmann-Stroissnigg H, Dai HM, Ling YY, Stout MB, et al. Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors. Aging Cell. 2016;15:428\u201335.","journal-title":"Aging Cell"},{"key":"3404_CR46","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1007\/s40265-017-0838-6","volume":"77","author":"A Markham","year":"2017","unstructured":"Markham A. Copanlisib: first global approval. Drugs. 2017;77:2057\u201362.","journal-title":"Drugs"},{"key":"3404_CR47","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrd.2016.253","volume":"16","author":"A Ashkenazi","year":"2017","unstructured":"Ashkenazi A, Fairbrother WJ, Leverson JD, Souers AJ. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors. Nat Rev Drug Discov. 2017;16:273\u201384.","journal-title":"Nat Rev Drug Discov"},{"key":"3404_CR48","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13602","volume":"21","author":"A Chandra","year":"2022","unstructured":"Chandra A, Lagnado AB, Farr JN, Doolittle M, Tchkonia T, Kirkland JL, et al. Targeted clearance of p21- but not p16-positive senescent cells prevents radiation-induced osteoporosis and increased marrow adiposity. Aging Cell. 2022;21:e13602.","journal-title":"Aging Cell"},{"key":"3404_CR49","doi-asserted-by":"publisher","first-page":"407","DOI":"10.4161\/cc.6.4.3855","volume":"6","author":"RU Janicke","year":"2007","unstructured":"Janicke RU, Sohn D, Essmann F, Schulze-Osthoff K. The multiple battles fought by anti-apoptotic p21. Cell Cycle. 2007;6:407\u201313.","journal-title":"Cell Cycle"},{"key":"3404_CR50","doi-asserted-by":"publisher","first-page":"11254","DOI":"10.1158\/0008-5472.CAN-06-1569","volume":"66","author":"D Sohn","year":"2006","unstructured":"Sohn D, Essmann F, Schulze-Osthoff K, Janicke RU. p21 blocks irradiation-induced apoptosis downstream of mitochondria by inhibition of cyclin-dependent kinase-mediated caspase-9 activation. Cancer Res. 2006;66:11254\u201362.","journal-title":"Cancer Res"},{"key":"3404_CR51","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.15252\/embj.201695553","volume":"36","author":"R Yosef","year":"2017","unstructured":"Yosef R, Pilpel N, Papismadov N, Gal H, Ovadya Y, Vadai E, et al. p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling. EMBO J. 2017;36:2280\u201395.","journal-title":"EMBO J"},{"key":"3404_CR52","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1158\/1535-7163.MCT-05-0184","volume":"4","author":"XN Li","year":"2005","unstructured":"Li XN, Shu Q, Su JM, Perlaky L, Blaney SM, Lau CC. Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC. Mol Cancer Ther. 2005;4:1912\u201322.","journal-title":"Mol Cancer Ther"},{"key":"3404_CR53","doi-asserted-by":"publisher","first-page":"4599","DOI":"10.1158\/0008-5472.CAN-17-4060","volume":"78","author":"G Pallavicini","year":"2018","unstructured":"Pallavicini G, Sgro F, Garello F, Falcone M, Bitonto V, Berto GE, et al. Inactivation of citron kinase inhibits medulloblastoma progression by inducing apoptosis and cell senescence. Cancer Res. 2018;78:4599\u2013612.","journal-title":"Cancer Res"},{"key":"3404_CR54","doi-asserted-by":"publisher","first-page":"3796","DOI":"10.1158\/0008-5472.CAN-13-0238","volume":"73","author":"J Ahlfeld","year":"2013","unstructured":"Ahlfeld J, Favaro R, Pagella P, Kretzschmar HA, Nicolis S, Schuller U. Sox2 requirement in sonic hedgehog-associated medulloblastoma. Cancer Res. 2013;73:3796\u2013807.","journal-title":"Cancer Res"},{"key":"3404_CR55","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.molmed.2016.03.006","volume":"22","author":"NJ Barthelery","year":"2016","unstructured":"Barthelery NJ, Manfredi JJ. Cerebellum development and tumorigenesis: a p53-centric perspective. Trends Mol Med. 2016;22:404\u201313.","journal-title":"Trends Mol Med"},{"key":"3404_CR56","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1200\/JCO.2012.48.5052","volume":"31","author":"N Zhukova","year":"2013","unstructured":"Zhukova N, Ramaswamy V, Remke M, Pfaff E, Shih DJ, Martin DC, et al. Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma. J Clin Oncol. 2013;31:2927\u201335.","journal-title":"J Clin Oncol"},{"key":"3404_CR57","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/bpa.12837","volume":"30","author":"BA Orr","year":"2020","unstructured":"Orr BA. Pathology, diagnostics, and classification of medulloblastoma. Brain Pathol. 2020;30:664\u201378.","journal-title":"Brain Pathol"},{"key":"3404_CR58","doi-asserted-by":"publisher","first-page":"a026278","DOI":"10.1101\/cshperspect.a026278","volume":"6","author":"V Ramaswamy","year":"2015","unstructured":"Ramaswamy V, Nor C, Taylor MD. p53 and meduloblastoma. Cold Spring Harb Perspect Med. 2015;6:a026278.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3404_CR59","doi-asserted-by":"publisher","first-page":"34742","DOI":"10.1074\/jbc.M602492200","volume":"281","author":"A Vigneron","year":"2006","unstructured":"Vigneron A, Cherier J, Barre B, Gamelin E, Coqueret O. The cell cycle inhibitor p21waf1 binds to the myc and cdc25A promoters upon DNA damage and induces transcriptional repression. J Biol Chem. 2006;281:34742\u201350.","journal-title":"J Biol Chem"},{"key":"3404_CR60","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1158\/1078-0432.CCR-13-2281","volume":"20","author":"P Bandopadhayay","year":"2014","unstructured":"Bandopadhayay P, Bergthold G, Nguyen B, Schubert S, Gholamin S, Tang Y, et al. BET bromodomain inhibition of MYC-amplified medulloblastoma. Clin Cancer Res. 2014;20:912\u201325.","journal-title":"Clin Cancer Res"},{"key":"3404_CR61","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.18632\/oncotarget.1659","volume":"5","author":"S Venkataraman","year":"2014","unstructured":"Venkataraman S, Alimova I, Balakrishnan I, Harris P, Birks DK, Griesinger A, et al. Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma. Oncotarget. 2014;5:2355\u201371.","journal-title":"Oncotarget"},{"key":"3404_CR62","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1002\/jcb.25863","volume":"118","author":"HT Zhang","year":"2017","unstructured":"Zhang HT, Gui T, Sang Y, Yang J, Li YH, Liang GH, et al. The BET Bromodomain Inhibitor JQ1 suppresses chondrosarcoma cell growth via regulation of YAP\/p21\/c-Myc signaling. J Cell Biochem. 2017;118:2182\u201392.","journal-title":"J Cell Biochem"},{"key":"3404_CR63","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/acel.12344","volume":"14","author":"Y Zhu","year":"2015","unstructured":"Zhu Y, Tchkonia T, Pirtskhalava T, Gower AC, Ding H, Giorgadze N, et al. The Achilles\u2019 heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell. 2015;14:644\u201358.","journal-title":"Aging Cell"},{"key":"3404_CR64","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1007\/s11357-023-00870-x","volume":"45","author":"R Gulej","year":"2023","unstructured":"Gulej R, Nyul-Toth A, Ahire C, DelFavero J, Balasubramanian P, Kiss T, et al. Elimination of senescent cells by treatment with Navitoclax\/ABT263 reverses whole brain irradiation-induced blood-brain barrier disruption in the mouse brain. Geroscience. 2023;45:2983\u20133002.","journal-title":"Geroscience"},{"key":"3404_CR65","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11357-020-00154-8","volume":"42","author":"A Yabluchanskiy","year":"2020","unstructured":"Yabluchanskiy A, Tarantini S, Balasubramanian P, Kiss T, Csipo T, Fulop GA, et al. Pharmacological or genetic depletion of senescent astrocytes prevents whole brain irradiation-induced impairment of neurovascular coupling responses protecting cognitive function in mice. Geroscience. 2020;42:409\u201328.","journal-title":"Geroscience"},{"key":"3404_CR66","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/nan.12689","volume":"47","author":"G Carreno","year":"2021","unstructured":"Carreno G, Guiho R, Martinez-Barbera JP. Cell senescence in neuropathology: a focus on neurodegeneration and tumours. Neuropathol Appl Neurobiol. 2021;47:359\u201378.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"3404_CR67","doi-asserted-by":"publisher","first-page":"5935","DOI":"10.1158\/0008-5472.CAN-21-0752","volume":"81","author":"E Fletcher-Sananikone","year":"2021","unstructured":"Fletcher-Sananikone E, Kanji S, Tomimatsu N, Di Cristofaro LFM, Kollipara RK, Saha D, et al. Elimination of radiation-induced senescence in the brain tumor microenvironment attenuates glioblastoma recurrence. Cancer Res. 2021;81:5935\u201347.","journal-title":"Cancer Res"},{"key":"3404_CR68","doi-asserted-by":"crossref","unstructured":"Kudlova N, De Sanctis JB, Hajduch M. Cellular senescence: molecular targets, biomarkers, and senolytic drugs. Int J Mol Sci. 2022;23:4168.","DOI":"10.3390\/ijms23084168"},{"key":"3404_CR69","doi-asserted-by":"publisher","first-page":"15915","DOI":"10.18632\/oncotarget.7432","volume":"7","author":"D Sohn","year":"2016","unstructured":"Sohn D, Peters D, Piekorz RP, Budach W, Janicke RU. miR-30e controls DNA damage-induced stress responses by modulating expression of the CDK inhibitor p21WAF1\/CIP1 and caspase-3. Oncotarget. 2016;7:15915\u201329.","journal-title":"Oncotarget"},{"key":"3404_CR70","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1038\/nprot.2009.191","volume":"4","author":"F Debacq-Chainiaux","year":"2009","unstructured":"Debacq-Chainiaux F, Erusalimsky JD, Campisi J, Toussaint O. Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc. 2009;4:1798\u2013806.","journal-title":"Nat Protoc"},{"key":"3404_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2024.102929","volume":"5","author":"S Magkouta","year":"2024","unstructured":"Magkouta S, Veroutis D, Pousias A, Papaspyropoulos A, Giannetti K, Pippa N, et al. One-step rapid tracking and isolation of senescent cells in cellular systems, tissues, or animal models via GLF16. STAR Protoc. 2024;5:102929.","journal-title":"STAR Protoc"},{"key":"3404_CR72","doi-asserted-by":"publisher","first-page":"e61438","DOI":"10.1371\/journal.pone.0061438","volume":"8","author":"S Pietkiewicz","year":"2013","unstructured":"Pietkiewicz S, Sohn D, Piekorz RP, Grether-Beck S, Budach W, Sabapathy K, et al. Oppositional regulation of Noxa by JNK1 and JNK2 during apoptosis induced by proteasomal inhibitors. PLoS One. 2013;8:e61438.","journal-title":"PLoS One"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03404-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03404-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03404-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:03:00Z","timestamp":1791478980000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03404-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3404"],"URL":"https:\/\/doi.org\/10.1038\/s41420-026-03404-4","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"assertion":[{"value":"14 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study did not require ethical approval as it was performed in established and available cell lines.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"410"}}